Camilla Beech

Camilla Beech is currently Director of her regulatory consultancy business specializing in novel biotechnology products and particularly genetically-modified insects.

For more than 30 years she has been involved in the forefront of contributing to policy, guidance, regulation and risk assessment of genetically-modified organisms and over the last 10 years has specialized predominantly in obtaining regulatory outcomes for genetically-modified insects for both agriculture and public health including obtaining permission for the first field release of a genetically-modified Aedes aegypti. She has also been a faculty member of training courses (funded by WHO-TDR) in genetically-modified vectors in Latin America, Africa and South-East Asia. She is currently interested in risk-benefit assessments for gene drives in mosquitoes for vector control and appropriate evaluation strategies.

Prior to setting up her own business, she led biotechnology regulatory affairs departments at Oxitec Ltd and Syngenta (and legacy companies). Having managed various regulatory portfolios and compliance programmes for a variety of biotechnology products worldwide she has a deep understanding of the attributes required for their safe use and efficacy.